SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-24-277849
Filing Date
2024-12-13
Accepted
2024-12-13 07:17:26
Documents
72
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d914517d10q.htm   iXBRL 10-Q 848019
2 EX-10.1 d914517dex101.htm EX-10.1 46720
3 EX-31.1 d914517dex311.htm EX-31.1 10950
4 EX-31.2 d914517dex312.htm EX-31.2 10916
5 EX-32.1 d914517dex321.htm EX-32.1 4242
6 EX-32.2 d914517dex322.htm EX-32.2 4211
  Complete submission text file 0001193125-24-277849.txt   4552546

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA grtx-20240930.xsd EX-101.SCH 39435
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE grtx-20240930_cal.xml EX-101.CAL 38197
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grtx-20240930_def.xml EX-101.DEF 102689
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE grtx-20240930_lab.xml EX-101.LAB 317341
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grtx-20240930_pre.xml EX-101.PRE 232856
75 EXTRACTED XBRL INSTANCE DOCUMENT d914517d10q_htm.xml XML 546564
Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39114 | Film No.: 241546786
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)